SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: AJAG who wrote (1789)2/19/1999 9:18:00 PM
From: Alan Cole  Read Replies (1) | Respond to of 10280
 
Is an improved version of Prozac going to be the best available SSRI (it's class of anti-depressant - there are other, newer SSRIs available)? If the purpose of a resigned version is to limit adverse effects, how is it likely to compare to Celexa, a new SSRI with improved adverse effect profile? In some cases, a new drug may be better then a reconfigured older one. Any thoughts on Prozac?